People: Corcept Therapeutics Inc (CORT.O)
30 Mar 2017
Mr. David L. Mahoney is an Independent Director of Corcept Therapeutics Inc. He is a private equity investor who has served as a member of Board since July 2004. From 1999 to 2001, Mr. Mahoney served as co- Chief Executive Officer of McKesson HBOC, Inc., a healthcare supply management and information technology company and as Chief Executive Officer of iMcKesson LLC, a healthcare management and connectivity company. He joined McKesson Corporation in 1990 as Vice President for Strategic Planning. Prior to joining McKesson, Mr. Mahoney was a principal with McKinsey & Company, a management consulting firm, where he worked from 1981 to 1990. Mr. Mahoney serves on the board of Symantec Corporation (Symantec), a publicly-traded software technology company, including as a member of its Compensation Committee and Nominating and Governance Committees; and Adamas Pharmaceuticals (Adamas), a publicly traded bio-pharmaceutical company where he is the Lead Independent Director, chairs the Nominating and Governance Committee and serves on the Compensation Committee. Mr. Mahoney also served as a member of the Audit Committee of Symantec from 2003 to 2011. He also serves on the board of directors of San Francisco Museum of Modern Art and Mercy Corps and is a Trustee of the Schwab/Laudis Family of Funds. Mr. Mahoney received his B.A. from Princeton University and his M.B.A. from Harvard University.
|Total Annual Compensation,||--|
|Restricted Stock Awards,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|